The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
Common antidepressant may help adults with long COVID: study
- 2026-04-02, 1:39 PM
- globalnews.ca
- 0
No comments